TAI'AN, China, August 8, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host its earnings conference call covering its second quarter 2011 results on August 10, 2011 at 7:00 a.m. EDT (New York), which is also 7:00 p.m. in China on the same day.
Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer.
The dial-in details for the live conference call are:
U.S. toll-free number | 1 866 549 1292 | |
Mainland China toll-free number | 800 876 8626 | |
Hong Kong local access | 3005 2050 | |
International toll number | +852 3005 2050 | |
Participant pass code | 674 477# | |
A telephone replay of the call will be available after the conclusion of the conference all through 7:00 a.m. EDT on August 17, 2011.
The dial-in details for the telephone replay are:
U.S. toll-free number | 1 866 753 0743 | |
Mainland China toll free number | 800 876 8594 | |
Hong Kong local access | 3005 2020 | |
International dial-in toll number | +852 3005 2020 | |
Replay pass code | 138 012# | |
About China Biologic Products, Inc.
China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently one of the leading plasma-based biopharmaceutical companies in China.
The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. Please see the Company's website at www.chinabiologic.com for additional information.
Company Contact | |
Mr. Y. Tristan Kuo | |
